NDC 76369-8010-1 - CLARA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76369-8010
- Requested NDC
- 76369-8010-1
- Package NDCs from labels
- 76369-8010-1, 76369-8010-2
- Manufacturer
- Handock Cosmetics Co., Ltd.
- Effective date
- 2018-07-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CLARA - Handock Cosmetics Co., Ltd. | Handock Cosmetics Co., Ltd. | 2018-07-13 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lactulose | LACTULOSE | APOZEAL PHARMACEUTICALS INC | a8af7389-3699-4873-b05a-509af7e8eaab | 2026-01-06 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Lactulose | LACTULOSE | Foxland Pharmaceuticals, Inc. | 3363bdbd-f0d1-45b3-8193-7fdb0a310cc2 | 2025-12-16 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Lactulose | LACTULOSE | Chartwell RX, LLC. | bd9f1577-65e8-4521-b176-e5fc60a4a018 | 2025-12-08 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2025-12-03 | Warnings | 0SHO53407G |
| SAMS WEST | PSYLLIUM HUSK | SAM'S WEST INC | 2aaf5d99-6d28-4fa6-b3c5-52dcfc94dac0 | 2025-11-20 | Warnings | 0SHO53407G |
| Lactulose | LACTULOSE | Chartwell Governmental & Specialty RX, LLC. | 887157ba-3c91-4fbf-bb12-b49c6fa4252c | 2025-11-13 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Topco Fiber Therapy Sugar Free | PSYLLIUM HUSK | TOPCO ASSOCIATES LLC | 2c61e73e-b3f7-4ab2-8bda-e65a2c0b3560 | 2025-11-10 | Warnings | 0SHO53407G |
| up and up fiber therapy | PSYLLIUM HUSK | Target Corporation | 674753ee-1174-4c06-9ed3-a090b338a39e | 2025-11-05 | Warnings | 0SHO53407G |
| up and up fiber therapy | PSYLLIUM HUSK | TARGET CORPORATION | 956c48f8-c705-4a86-9866-c68a48ddeb6c | 2025-11-05 | Warnings | 0SHO53407G |
| Target Fiber Laxative | PSYLLIUM HUSK | TARGET CORPORATION | a581116a-392d-4ac3-ae15-4318506a7b2a | 2025-11-04 | Warnings | 0SHO53407G |
| up and up fiber therapy Natural Fiber | PSYLLIUM HUSK | Target Corporation | f8b1c831-6fd0-4a58-9726-4e0f986c8084 | 2025-11-04 | Warnings | 0SHO53407G |
| PUBLIX | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | 55f98d3f-f282-4f19-b373-0b59640d274d | 2025-10-28 | Warnings | 0SHO53407G |
| Publix Fiber Therapy Orange Smooth | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | b9c54c20-cd82-4627-9217-a66834db4799 | 2025-10-28 | Warnings | 0SHO53407G |
| Publix Fiber Therapy Sugar Free | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | ed3dc80a-a243-4013-9886-b148e3e3b662 | 2025-10-28 | Warnings | 0SHO53407G |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | The Procter & Gamble Manufacturing Company | a9824f73-5ea2-4a65-a926-3a57561441b8 | 2025-10-01 | Warnings | 0SHO53407G |
| LACTULOSE | LACTULOSE | Atlantic Biologicals Corp. | 3fb6e908-893c-5a57-e063-6294a90a1bfc | 2025-09-26 | Warnings, Adverse reactions | 9U7D5QH5AE |
| LACTULOSE | LACTULOSE | PAI Holdings, LLC dba PAI Pharma | 0f19e4ed-c90a-4330-a7fa-bf911aa98f09 | 2025-09-15 | Warnings, Adverse reactions | 9U7D5QH5AE |
| LACTULOSE | LACTULOSE | PAI Holdings, LLC dba PAI Pharma | cbf0497c-9c8d-4dfa-bebd-64c589468401 | 2025-09-15 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Lactulose | LACTULOSE | Trifluent Pharma, Inc. | 3eaf273a-b49d-2595-e063-6394a90a1cf6 | 2025-09-13 | Warnings, Adverse reactions | 9U7D5QH5AE |
| LACTULOSE Crystalline | LACTULOSE | Cumberland Assured Products Inc. | 59e75426-42ae-4904-941f-009181101a8a | 2025-09-01 | Warnings, Adverse reactions | 9U7D5QH5AE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.